The first veterinary blockchain aiming at health and longevityWhat TAILS tokens?
This project is about:
What is HealthyTail?HealthyTail is a project devoted to health and longevity of cats and dogs - most popular domesticated pets. By using next-generation sequencing technology and by processing a very large amount of genomic data it is possible to identify disease-specific genomic variation patterns and provide a personalized treatment and recommendations for a pet.
Take care of the health of your animal before it gets illjoin us
The team consists of the first in the world bioinformaticians, geneticists, biologists, pet owners, veterinarians and seasoned IT professionals. They have a proven track record for pet genetics and high-cited publications.
13 years in IT. R&D Storage and
Compute Solutions expert.
Ideologist of EMC Bioinformatics solution
presented on BioIT World 2015.
Big Data expert, Data Science challenges winner.
US patents & scientific publications author. Supervisor of projects total cap $50m.
Entrepreneur, BOINC activist, investor in cryptocurrencies and stocks.
Expert in startup community.
Training and teaching in Europe and USA.
Experience of the management of R&D projects in biotechnologies more than 15 years.
A lot of inventions and more
than 40 patents registered.
Inventions were included in TOP 100
of inventions of Russia 2015.
Worked for SMB Services in Molecular Biology GmBH.
PhD in Biology by Humboldt-Universität zu Berlin, Germany.
MSc in Zoology by Universidade de São Paulo, Brazil.
Expert in Next generation sequencing data analysis and genomics of non-model organisms.
Expert in genome repeats studies. Expert in NLP, ML and DeepLearning.
Co-author of “Annotated features of domestic pet – Felis petus genome” 2014. GigaScience 3(1), 13.
More than 20 high-cited publications about animal genomes and annotations.
Worked for Theodosius Dobzhansky Center since its' foundation in 2011.
Expert in GWAS (Genome-Wide Association Studies), virology, epidemiology, HIV.
Co-author of the GWATCH web platform (Genome-Wide Association Tracks Chromosome Highway).
Genomic pipeline and sequencing
Bioinformatics tools author.
Knows more than 10 programming languages. Software architect. System administrator & Security specialist. Crypto enthusiast.
Animal heart diseases diagnostics specialist. Official veterinary of a horse racing club.
Developer of a technology “Plasmolifting-animal”.
Local veterinary community leader. Animal breeders & clubs advisor.
Experience of management of teams up to 250 people and projects annual budget over $30m.
The managing director of the company entering in TOP-10 in finance sphere, the co-founder of startup in biotech R&D.
Experience in launching partner projects with IKEA, Sberbank, the Russian Railway, St.Petersburg Bank, Svyaznoy, VIM-Airlines, Rostelecom, Anywayanyday.com and others.
Postgraduate student in cytology and histology in St.Petersburg State University.
Expertise in international research cooperation management between leading universities worldwide and international educational consulting,
marketing analytics and public relations within university foreign affairs policy for St. Petersburg State University.
Worked for international outdoor company Red Fox (marketing and PR management).
Journalist in several popular science magazines.
The proud owner (and the best friend) of Manny the cat.
Making science and technology understandable since 2011.
Chief of the Laboratory of Genomic Diversity at the National Cancer Institute (NCI), National Institutes of Health (NIH) from 1986 to 2011.
Founder of Genome10K project.
Dr. O’Brien is the author or co-author of over 800 scientific articles and the editor of fourteen volumes.
Ph.D., recognized globally for his research on the basic biology of aging. The premise of his research is that understanding the molecular mechanisms of aging will lead to interventions that slow the onset and progression of age-related chronic conditions, such as cancer, diabetes, kidney disease, heart disease, Alzheimer’s and others. The Kaeberlein Lab is located in the University of Washington Medical Center in Seattle. The lab has been in operation as part of the UW Pathology Department since March 1, 2006. Dr. Matt Kaeberlein is the primary investigator. Dr. Kaeberlein has been recognized with several awards, including a Breakthroughs in Gerontology Award from the Glenn Foundation, an Alzheimer’s Association Young Investigator Award, an Ellison Medical Foundation New Scholar in Aging Award, an Undergraduate Research Mentor of the Year Award, and a Murdock Trust Award. In 2011, he was named the Vincent Cristofalo Rising Star in Aging Research by the American Federation for Aging Research and appointed as a Fellow of the Gerontological Society of America, and in 2012 he joined the Board of Directors of the American Aging Association. Dr. Kaeberlein currently serves on the editorial boards for Science, Aging Cell, Cell Cycle, PloS One, Frontiers in Genetics of Aging, BMC Longevity and Healthspan, F1000 Research, Ageing Research Reviews, and BioEsssays. Dr. Kaeberlein is the Director of the Dog Aging Project, co-Director of the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging, the founding Director of the Healthy Aging and Longevity Research Institute, and the current President of the American Aging Association.
Entrepreneur in genetics, diagnostics and drug design
Expert in animal genetics and molecular genetics. Fields of scientific interests: nuclear export of RNA, spermatogenesis.
Author of more than 20 publications in international science journals.
2007: PhD in Molecular Biology in the laboratory of Pierre-Antoine Defossez. Curie Institute Paris (France).
2008-2011: Postdoctoral research associate in the laboratory of Bas van Steensel. The Netherlands Cancer Institute, Amsterdam.
2012: Group Leader at the Center for Genomic Regulation (CRG) Barcelona, Spain.
2012 RISE1 member of the EpiGeneSys network.
EDITORIAL EXPERIENCE PLOS Computational Biology PLOS Genetics
2015: Zerone https://github.com/nanakiksc/zerone
2014: Seeq https://github.com/ezorita/seeq
2014: Starcode https://github.com/gui11aume/starcode
TAILS project brings in a unique opportunity to invest in longevity for everyone and your pet. Each stage of the project has added value, potential patents for the new drug design, and potential new our drugs based on plasmid for pet or human.
Our financial model expects the following revenue and costs:
|15%||Drug Design & registration|
|7%||Reagents & materials|
|7%||Logistics, Assets, IT|
|4%||Accountant + Lawyer|
Earnings after 3 years
|48%||Diagnostics, mating, certification|
Earnings in 5 years
In 5 years the data and drugs will become the main driver of the economy - we will see that competitors, especially big pharma will be interested in the data network and will pay a lot for data to compete with HealthyTail - as we would like to benefit the community the target is not to own the market rather the goal is to build a new pet data economy.
|9%||Diagnostics, mating, certification|
A portrait of
a long-lived cat
Cats in the
Cats in the
blockchain, part 2
Cats in the
Feel free to write us. We are always in touch with the community
+79214038423 - Vladimir Suvorov